HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Two cases of extramedullary myeloid tumor in patients with continuous remission of acute myeloblastic leukemia.

Abstract
Myeloid sarcoma is described as tumor mass consisting of myeloblasts or immature myeloid cells, involving extramedullary tissues. It can be initial manifestation of myeloproliferative disorders or relapse of previously treated acute myeloblastic leukemia (AML). We present two patients, one with AML-M2 and the other with acute promyelocytic leukemia (APL)-M3. After remission induced by conventional chemotherapy, which continued for 3 and 10 years respectively, a myeloid sarcoma was diagnosed. Biopsy of a retroauricular tumor formation was made in the first case. The second one was diagnozed after biopsy of a supraclavicular lymph node. In both cases complete laboratory investigation including blood smear, differential counting and flow cytometric analysis of bone marrow were normal. Despite this, the patients received chemotherapy. The APL-M3 patient was treated with radiotherapy to the involved supraclavicular lymph node which was followed by chemotherapy. Three months after radiotherapy bone marrow infiltration and blast cells in the peripheral blood were found. Two years after the diagnosis of myeloid sarcoma the patient died of haemorrhagic stroke. The patient with AML-M2 continued treatment with polychemotherapy.
AuthorsV Slavcheva, Tz Lukanov, N Tzvetkov
JournalJournal of B.U.ON. : official journal of the Balkan Union of Oncology (J BUON) 2008 Oct-Dec Vol. 13 Issue 4 Pg. 589-92 ISSN: 1107-0625 [Print] Cyprus
PMID19145688 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Female
  • Humans
  • Leukemia, Myeloid, Acute (pathology)
  • Leukemia, Promyelocytic, Acute (pathology)
  • Middle Aged
  • Recurrence
  • Sarcoma, Myeloid (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: